Amneal Pharmaceuticals, Inc. Class A Common Stock
AMRX
$17.92+0.79%
End of day · as of Aug 26, 2026, 8:08 AM ET
Mkt cap
$5.19B
EV/Sales
2.48
P/E ratio
N/A
FY2025 Revenue
$3.02B
EPS (TTM)
$0.48
Gross Margin (FY2025)
36.88%
Profit Margin (FY2025)
2.39%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AMRX revenue for 2025-12-31 was $3.02B. Net income was $72.1M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. AMRX currently screens at market cap $5.19B.
Use this AMRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AMRX income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue for Dec 31, 2025 was $3.02B. Net income was $72.1M. Statements: https://lician.com/financials/amrx
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) market capitalization is $5.19B on the latest cached snapshot.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) cached previous close $17.78; day range $17.61 – $17.96; volume 1,093,047. Session quote: https://lician.com/quote/amrx
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) latest cached earnings event is "AMRX earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AMRX filing is 8-K · Aug 3, 2026. Filings: https://lician.com/sec/amrx